MI
KWON KIM
Profesor asociado de Ciencias de la Salud
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Hospital de la Santa Creu i Sant Pau (16)
2024
-
Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO
Transplantation and Cellular Therapy, Vol. 30, Núm. 10, pp. 988.e1-988.e11
-
Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies
Bone Marrow Transplantation
-
Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in Spain
Transplantation and Cellular Therapy, Vol. 30, Núm. 10, pp. 1033.e1-1033.e8
2023
-
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
Haematologica, Vol. 108, Núm. 1, pp. 110-121
-
Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era (Bone Marrow Transplantation, (2023), 58, 6, (673-679), 10.1038/s41409-023-01949-x)
Bone Marrow Transplantation
-
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study
Transplantation and Cellular Therapy, Vol. 29, Núm. 12, pp. 747.e1-747.e10
-
Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation
European Journal of Haematology, Vol. 110, Núm. 6, pp. 659-668
-
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era
Bone Marrow Transplantation, Vol. 58, Núm. 6, pp. 673-679
2022
-
CT-275 Incidence and Characteristics of Chronic GVHD in Haploidentical Stem-Cell Transplantation With Post-Transplantation Cyclophosfamide: Experience of the Spanish Group of Hematopoietic Transplantation and Cell Therapy (GETH-TC)
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S440-S441
2021
-
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
Leukemia, Vol. 35, Núm. 10, pp. 2885-2894
-
Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma
Cancer Medicine, Vol. 10, Núm. 10, pp. 3214-3223
-
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper
Infection, Vol. 49, Núm. 2, pp. 215-231
2019
-
Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders
AIDS, Vol. 33, Núm. 9, pp. 1441-1447
2018
-
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms
Blood Advances, Vol. 2, Núm. 14, pp. 1719-1737
2017
-
Single umbilical cord blood with or without CD341 cells from a third-party donor in adults with leukemia
Blood Advances, Vol. 1, Núm. 15, pp. 1047-1055